Federal Register Notice: FDA’s proposed collection of information, “Adverse Experience Reporting For Licensed Biological Products; and General Records — 21 CFR Part 600,” has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. To view this notice, click here.
